Abstract
Taurine has antioxidant like qualities in a variety of tissues including the lung and kidney. We developed a taurine deficient mouse model making it possible to study the antioxidant capabilities of taurine. Three groups of genetically manipulated mice included (1) third generation homozygote for taurine deficiency (G3 HO), (2) third generation homozygote for taurine deficiency with parents treated with 0.05 % taurine (G3 HOT) in the drinking water and (3) a control wild type (WT) with normal taurine levels. Lung and kidney tissues were embedded in epon, 1 μm sections were cut, stained with methylene blue and Azure II and observed by light microscopy. Representative areas were chosen for ultrathin sectioning and observation by electron microscopy. Both the lung and the kidney exhibited alterations in G3 HO and G3 HOT. Alterations in the kidney included the distal tubules in both G3 HO and G3 HOT. In the kidney, the absence of taurine may cause injury to the distal tubules by unregulated osmolarity within the cells. In the lung, there is an increase in phagocytic cell infiltrates, PMNs and macrophages along with increased surfactant and edema in both groups including G3 HO and G3 HOT. Taurine deficient may have changes in the lung as evidence by osmolarity, in addition to oxidant injury at both epithelial and endothelial cells, leading to the presence of edema and increased production of surfactant. The data indicate that 0.05 % taurine in the drinking water is not sufficient for protection from injury. This animal model, paralleling many diseases of the kidney and lung will allow a better understanding of the role of taurine in various diseases and help to find more effective ways of treatment and prevention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CDO:
-
Cysteine dioxygenase
- CDO KO:
-
Cysteine dioxygenase knockout mice
- CSAD:
-
Cysteine sulfinic acid decarboxylase
- CSAD KO:
-
Cysteine sulfinic acid decarboxylase knockout mice
- G1 G2, G3:
-
Generation 1, 2 and 3
- G1 HO:
-
HO (CSAD−/−) mice born from HT (CSAD+/−) parents
- G2 or G3 HO:
-
Mice born from G1 HO or G2 HO parents
- HO:
-
Homozygotic mice (CSAD−/−)
- HOT:
-
Homozygotic mice treated with 0.05 % taurine
- HT:
-
Heterozygotic mice (CSAD+/−)
- WT:
-
Wild type (CSAD+/+)
References
Burg MB (1994) Molecular basis for osmoregulation of organic osmolytes in renal medullary cells. J Exp Zool 268(2):171–175
Burg MB, Ferras JD, Dmitrieva NJ (2007) Cellular response to hyperosmotic stresses. Physiol Rev 87(4):1441–1474
Chesney RW, Han X, Patters AB (2010) Taurine and the renal system. J Biomed Sci 17(Suppl 1):S4
Choi YJ, Lee EY, Yadav D, Chung CH (2014) Taurine alleviates the progression of diabetic nephropathy in type 2 diabetic rat model. Int J Endocrinol 2014:397307. doi:10.1155/2014/397307
Dantzler WH, Silbernagl S (1976) Renal tubular reabsorption of taurine, gamma-aminobutyric acid (GABA) and beta-alanine studied by continuous microperfusion. Pflugers Arch 367(2):123–128
Gordon RE, Heller R, Heller R (1992) Taurine protection of lungs in hamster models of oxidant injury. In: Lombardine JB, Schaffer SW, Azuma J (eds) Taurine 3, nutritional value and mechanisms of action. Plenum Press, New York, NY, pp 319–328
Gordon R, Park E, Schuller-Levis G (1998) Taurine protects rat bronchioles from acute ozone exposure: a freeze fracture and electron microscopic study. Exp Lung Res 24:659–674
Guler L, Tavlasoglu M, Yucel O, Guler A, Sahin MA, Kurkluoglu M, Sirin Y, Eken A, Gamsizkan M, Dakak M, Gurkok S, Genc O (2014) Taurine attenuates lung ischemia-reperfusion injury after lung transplantation in rats. J Anesth 28(3):347–353
Han X, Chesney RW (2012) The role of taurine in renal disorders. Amino Acids 43(6):2249–2263. doi:10.1007/s00726-012-1314-y
Handler JS, Kwon HM (1997) Kidney cell survival in high tonicity. Comp Biochem Physiol A Physiol 117(3):301–306
Handler JS, Kwon HM (2001) Transcriptional regulation by change in tonicity. Kidney Int 60(2):408–411
Hayslett JP, Kashgarian M, Epstein FH (1967) Changes in proximal and distal tubular reabsorption produced by rapid expansion of extracellular fluid. J Clin Invest 46(7):1254–1263
Heller-Stilb B, van Royen C, Rascher K, Hartwig HG, Huth A, Seeliger MW, Warskulat U, Haeussinger D (2002) Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J 16:231–233
Huxtable RJ (2000) Expanding the circle 1975–1999: sulfur biochemistry and insights on the biological functions of taurine. Adv Exp Med Biol 483:1–25
Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J (2008) Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J. Mol. Cell. Cardiol. 44:927-937
Jeon SH, Lee MY, Rahman MM, Kim SJ, Kim GB, Park SY, Hong CU, Kim SZ, Kim JS, Kang HS (2009) The antioxidant, taurine reduced lipopolysaccharide (LPS)-induced generation of ROS, and activation of MAPKs and Bax in cultured pneumocytes. Pulm Pharmacol Ther 22(6):562–566
Koh JH, Lee ES, Hyun M, Kim HM, Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J (2008) Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 44:927–937
Michalk DV, Wingenfeld P, Licht C, Ugur T, Siar LF (1996) The mechanisms of taurine mediated protection against cell damage induced by hypoxia and reoxygenation. Adv Exp Med Biol 403:223–232
Mozaffari MS, Abdelsayed R, Patel C, Wimborne H, Liu JY, Schaffer SW (2010) Differential effects of taurine treatment and taurine deficiency on the outcome of renal ischemia reperfusion injury. J Biomed Sci 17(Suppl 1):S32
Park E, Park YS, Dobkin C, Schuller-Levis G (2014a) Development of a novel cysteine sulfinic acid decarboxylase knockout mouse: dietary taurine reduces neonatal mortality. J Amino Acids Article ID 346809:1–11. http://dx.doi.org/10.1155/2014/346809
Schuller-Levis GB, Park E (2003) Taurine: new implications for an old amino acid. FEMS Microbiol Lett 226:195–202
Schuller-Levis G, Park E (2006) Is taurine a biomarker? Adv Clin Chem 41:1–21
Schuller-Levis G, Gordon RE, Park E, Pendino KJ, Laskin D (1995) Taurine protects rat bronchioles from acute ozone-induced lung inflammation and hyperplasia. Exp Lung Res 21:877–888
Schuller-Levis G, Gordon R, Wang C, Park E (2003) Taurine reduces lung inflammation and fibrosis caused by bleomycin. Adv Exp Med Biol 562:395–402
Schuller-Levis G, Gordon R, Wang C, Park S, Park E (2009) Protection of bleomycin-induced fibro-sis and inflammation by taurine. Int Immunopharmacol 9:971–977
Stipanuk MH (2004) Role of the liver in regulation of body cysteine and taurine levels: a brief review. Neurochem Res 29:105–110
Sturman JA (1993) Taurine in development. Physiol Rev 73:119–146
Trachtman H, Futterweit S, Bienkowski RS (1993) Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Biochem Biophys Res Commun 191(2):759–765
Uchida S, Kwon HM, Yamauchi A, Preston AS, Marumo F, Handler JS (1992) Molecular cloning of the cDNA for an MDCK cell Na(+)- and Cl (-)-dependent taurine transporter that is regulated by hypertonicity. Proc Natl Acad Sci U S A 89:8230–8234
Ueki I, Roman HB, Valli A, Fieselmann K, Lam J, Peters R, Hirschberger LL, Stipanuk MH (2011) Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide. Am. J. Physiol. Endocrinol. Metab. 301:E668-684
Wang Q, Giri SN, Hyde DM, Li C (1991) Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem Pharmacol 42:1115–1122
Yucel O, Kunak ZI, Macit E, Gunal A, Gozubuyuk A, Gul H, Genc O (2008) Protective efficacy of taurine against pulmonary edema progression: experimental study. J Cardiothorac Surg 3:57
Acknowledgements
This work was supported by the Office for People with Developmental Disabilities, Albany, NY and Dong A Pharmaceutical Co., LTD, Seoul, Korea. We are thankful to Dr. William Levis for discussing the research and reviewing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this paper
Cite this paper
Gordon, R., Park, S.Y., Schuller-Levis, G., Park, E. (2015). A Novel Cysteine Sulfinic Acid Decarboxylase Knock-Out Mouse: Pathology of the Kidney and Lung in Newborn Pups. In: Marcinkiewicz, J., Schaffer, S. (eds) Taurine 9. Advances in Experimental Medicine and Biology, vol 803. Springer, Cham. https://doi.org/10.1007/978-3-319-15126-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-15126-7_2
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15125-0
Online ISBN: 978-3-319-15126-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)